Paladin Capital Group
  • About Us
  • Investment Principles & Commitments
  • Cyber Fund II
  • AI Investing
  • Entrepreneurs
  • Our Portfolio
  • Our Team
  • News
  • Paladin Global Institute
Select Page

10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Sep 16, 2019

PLEASANTON, Calif., Sept. 16, 2019 — 10x Genomics (Nasdaq: TXG) today announced the closing of its initial public offering of 11,500,000 shares of its Class A common stock, which includes the exercise in full of the underwriters’ option to purchase 1,500,000...
Page 30 of 30« First«...1020...2627282930

Recent news

  • Paladin Capital Names Longtime Strategic Advisors as Managing Directors, Expands Executive Leadership Team
  • Paladin Portfolio Company SandboxAQ Receives $500 Million From U.S. Commerce Department for Critical Chip Manufacturing R&D
  • Paladin Global Institute Releases a Governance Layer Primer to Encourage Trustworthy AI Development
  • Strategic Advisor Chris Inglis Honored with INSA William Oliver Baker Award, Highly Prestigious Distinction in U.S. National Security
  • Arpio Raises $15 Million to Advance AI-Native Automated Recovery Platform for Cloud Environments

About Paladin

  • About Paladin Capital
  • History
  • Causes We Support
  • Contact Us

Follow Us

  • Twitter

Our Team

  • Management
  • Global Security Experts
  • Investment Professionals
  • Venture Partners
  • Strategic Advisory Group
  • Operations

Offices

  • Washington, DC
  • New York, NY
  • Silicon Valley, CA
  • London, UK
  • Luxembourg

Latest News

  • Paladin Capital Names Longtime Strategic Advisors as Managing Directors, Expands Executive Leadership Team August 5, 2026
  • Paladin Portfolio Company SandboxAQ Receives $500 Million From U.S. Commerce Department for Critical Chip Manufacturing R&D June 18, 2026

©2026 Paladin Capital Group - All Rights Reserved | Privacy Policy | Compliance Statement